Paul Richard Gotti

Title: Paul Richard Gotti: Innovator in Leukocyte Isolation and Radiolabeling

Introduction

Paul Richard Gotti is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of medical technology, particularly in the isolation and radiolabeling of leukocytes. His innovative methods have the potential to enhance various medical applications, especially in vivo studies.

Latest Patents

Gotti holds a patent for a method titled "Method for isolating and radiolabeling leukocytes for use in vivo." This patent discloses a technique for separating leukocytes from platelets. The process involves adding blood serum to a centrifuge tube, followed by a suspension containing leukocytes and platelets. This mixture forms a layer on top of the blood serum, which has a lower density than the serum itself. The cells are then centrifuged to effectively separate the leukocytes from the platelets. The isolated leukocytes can be recovered from the centrifuge tube for further use. In certain embodiments, the leukocyte suspension is pretreated with a stannous ion reducing agent before being incubated with a technetium-99m (VII) salt solution to radiolabel the leukocyte cells.

Career Highlights

Gotti's career is marked by his dedication to advancing medical technology through innovative solutions. His work at Syncor International Corporation has allowed him to focus on developing methods that improve the efficiency and effectiveness of medical procedures involving leukocytes.

Collaborations

Gotti collaborates with Trenton Todd Rees, who is also involved in similar fields of research and innovation. Their partnership contributes to the advancement of techniques in leukocyte handling and application.

Conclusion

Paul Richard Gotti's contributions to the field of medical technology through his patent on leukocyte isolation and radiolabeling demonstrate his commitment to innovation. His work has the potential to significantly impact medical research and applications.